Der Nervenarzt

, Volume 75, Issue 10, pp 953–961 | Cite as

Spontane intrazerebrale Blutungen



Spontane intrazerebrale Blutungen (ICBs) sind für ca. 8–15% aller Schlaganfälle verantwortlich, bei Patienten unter oraler Antikoagulation sogar bis zu 40%. Die Mortalität und Morbidität sind wesentlich höher als beim ischämischen Schlaganfall. Über die Behandlungsmöglichkeiten in der Akutsituation gibt es nur wenig Daten aus randomisierten kontrollierten Therapiestudien. In dieser Übersicht soll die aktuelle Datenlage zusammengefasst und darauf basierend sollen Empfehlungen zur Behandlung von ICBs gegeben werden.


ICB Schlaganfall Therapie 

Spontaneous intracerebral hemorrhages


Spontaneous intracerebral hemorrhage (ICH) accounts for 8–15% of all cases of stroke and among patients receiving oral anticoagulants this number increases up to 40%. Mortality and morbidity are considerably higher in patients with ICH compared to patients with ischemic stroke. Large randomized controlled trials provide only little evidence for therapeutic strategies in patients with spontaneous ICH. In this review we summarize the available data and give recommendations on the management of spontaneous ICH.


ICH Stroke Therapy 


  1. 1.
    Arakawa S, Saku Y, Ibayashi S et al. (1998) Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 29:1806–1809PubMedGoogle Scholar
  2. 2.
    Ariesen MJ, Claus SP, Rinkel GJ et al. ( 2003) Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34:2060–2065CrossRefPubMedGoogle Scholar
  3. 3.
    Azzimondi G, Bassein L, Nonino F et al. (1995) Fever in acute stroke worsens prognosis. A prospective study. Stroke 26:2040–2043PubMedGoogle Scholar
  4. 4.
    Babikian VL, Kase CS, Pessin MS et al. (1988) Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves. Stroke 19:407–408Google Scholar
  5. 5.
    Bamford J, Sandercock P, Dennis M et al. (1990) A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project—1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53:16–22PubMedGoogle Scholar
  6. 6.
    Berger AR, Lipton RB, Lesser ML et al. (1988) Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 38:1363–1365PubMedGoogle Scholar
  7. 7.
    Bertram M, Bonsanto M, Hacke W et al. (2000) Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 247:209–214CrossRefPubMedGoogle Scholar
  8. 8.
    Berwaerts J, Dijkhuizen RS, Robb OJ et al. (2000) Prediction of functional outcome and in-hospital mortality after admission with oral anticoagulant-related intracerebral hemorrhage. Stroke 31:2558–2562PubMedGoogle Scholar
  9. 9.
    Boulis NM, Bobek MP, Schmaier A et al. (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113–1118PubMedGoogle Scholar
  10. 10.
    Broderick JP, Adams HP Jr, Barsan W et al. (1999) Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905–915PubMedGoogle Scholar
  11. 11.
    Broderick JP, Brott TG, Duldner JE et al. (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993PubMedGoogle Scholar
  12. 12.
    Brott T, Broderick J, Kothari R et al. (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5PubMedGoogle Scholar
  13. 13.
    Brott T, Thalinger K, Hertzberg V (1986) Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17:1078–1083PubMedGoogle Scholar
  14. 14.
    Burn J, Dennis M, Bamford J et al. (1997) Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 315:1582–1587PubMedGoogle Scholar
  15. 15.
    Butler AC, Tait RC (1998) Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 103:1064–1066CrossRefPubMedGoogle Scholar
  16. 16.
    Butler A, Tait RC (2004) Restarting oral anticoagulation after intracranial hemorrhage. Stroke 35:e5–6CrossRefPubMedGoogle Scholar
  17. 17.
    Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89:635–641PubMedGoogle Scholar
  18. 18.
    Dandapani BK, Suzuki S, Kelley RE et al. (1995) Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26:21–24PubMedGoogle Scholar
  19. 19.
    Daverat P, Castel JP, Dartigues JF et al. (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6PubMedGoogle Scholar
  20. 20.
    Dennis MS (2003) Outcome after brain haemorrhage. Cerebrovasc Dis 16(Suppl 1):9–13Google Scholar
  21. 21.
    Diringer MN (1993) Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 21:1591–1603PubMedGoogle Scholar
  22. 22.
    Eckman MH, Rosand J, Knudsen KA et al. (2003) Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34:1710–1716CrossRefPubMedGoogle Scholar
  23. 23.
    Fernandes HM, Gregson B, Siddique S et al. (2000) Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 31:2511–2516PubMedGoogle Scholar
  24. 24.
    Fiebach JB, Schellinger PD, Gass A et al. (2004) Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging. Stroke 35:502–506CrossRefPubMedGoogle Scholar
  25. 25.
    Fogelholm R, Avikainen S, Murros K (1997) Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28:1396–400PubMedGoogle Scholar
  26. 26.
    Fogelholm R, Eskola K, Kiminkinen T et al. (1992). Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 55:1121–1124PubMedGoogle Scholar
  27. 27.
    Franke CL, de Jonge J, van Swieten JC et al. (1990) Intracerebral hematomas during anticoagulant treatment. Stroke 21:726–730PubMedGoogle Scholar
  28. 28.
    Franke CL, van Swieten JC, Algra A et al. (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657PubMedGoogle Scholar
  29. 29.
    Fredriksson K, Norrving B, Stromblad LG (1992) Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23:972–977PubMedGoogle Scholar
  30. 30.
    Fujii Y, Takeuchi S, Sasaki O et al. (1998) Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29:1160–1166PubMedGoogle Scholar
  31. 31.
    Fujitsu K, Muramoto M, Ikeda Y et al. (1990) Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 73:518–525PubMedGoogle Scholar
  32. 32.
    Furlan AJ, Whisnant JP, Elveback LR (1979) The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 5:367–373PubMedGoogle Scholar
  33. 33.
    Gorter JW (1999) Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 53:1319–1327PubMedGoogle Scholar
  34. 34.
    Halpin SF, Britton JA, Byrne JV et al. (1994) Prospective evaluation of cerebral angiography and computed tomography in cerebral haematoma. J Neurol Neurosurg Psychiatry 57:1180–1186PubMedGoogle Scholar
  35. 35.
    Hardemark HG, Wesslen N, Persson L (1999) Influence of clinical factors, CT findings and early management on outcome in supratentorial intracerebral hemorrhage. Cerebrovasc Dis 9:10–21CrossRefPubMedGoogle Scholar
  36. 36.
    Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26:1471–1477PubMedGoogle Scholar
  37. 37.
    Hemphill JC 3rd, Bonovich DC, Besmertis L et al. (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897PubMedGoogle Scholar
  38. 38.
    Hylek EM, Go AS, Chang Y et al. (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026CrossRefPubMedGoogle Scholar
  39. 39.
    Hylek EM, Singer DE (1994) Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120:897–902PubMedGoogle Scholar
  40. 40.
    Inagawa T (2002) What are the actual incidence and mortality rates of intracerebral hemorrhage? Neurosurg Rev 25:237–246CrossRefPubMedGoogle Scholar
  41. 41.
    Italian Acute Stroke study group (1988) Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 13:318–321Google Scholar
  42. 42.
    Juvela S (1995) Risk factors for impaired outcome after spontaneous intracerebral hemorrhage. Arch Neurol 52:1193–1200PubMedGoogle Scholar
  43. 43.
    Kase CS, Robinson RK, Stein RW et al. (1985) Anticoagulant-related intracerebral hemorrhage. Neurology 35:943–948PubMedGoogle Scholar
  44. 44.
    Kazui S, Naritomi H, Yamamoto H et al. (1996) Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1783–1787Google Scholar
  45. 45.
    Klungel OH, Kaplan RC, Heckbert SR et al. (2000) Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients. Stroke 31:420–424PubMedGoogle Scholar
  46. 46.
    Landefeld CS, Goldman L (1989) Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87:144–152PubMedGoogle Scholar
  47. 47.
    Leker RR, Abramsky O (1998) Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 50:1489–1491PubMedGoogle Scholar
  48. 48.
    Lisk DR, Pasteur W, Rhoades H et al. (1994) Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44:133–139PubMedGoogle Scholar
  49. 49.
    Morgenstern LB, Demchuk AM, Kim DH et al. (2001) Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56:1294–1299PubMedGoogle Scholar
  50. 50.
    Mutlu N, Berry RG, Alpers BJ (1963) Massive cerebral hemorrhage. Clinical and pathological correlations. Arch Neurol 144:644–661PubMedGoogle Scholar
  51. 51.
    Naff NJ, Carhuapoma JR, Williams MA et al. (2000) Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31:841–847PubMedGoogle Scholar
  52. 52.
    Neal B, MacMahon S, Chapman N et al. (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists’ collaboration. Lancet 356:1955–1964PubMedGoogle Scholar
  53. 53.
    Neau JP, Couderq C, Ingrand P et al. (2001) Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis 11:195–200CrossRefPubMedGoogle Scholar
  54. 54.
    Nilsson OG, Lindgren A, Brandt L et al. (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531–536PubMedGoogle Scholar
  55. 55.
    Nilsson OG, Lindgren A, Stahl N et al. (2000) Incidence of intracerebral and subarachnoid haemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 69:601–607CrossRefPubMedGoogle Scholar
  56. 56.
    O’Donnell HC, Rosand J, Knudsen KA et al. (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342:240–245CrossRefPubMedGoogle Scholar
  57. 57.
    Passero S, Rocchi R, Rossi S et al. (2002) Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 43:1175–1180CrossRefPubMedGoogle Scholar
  58. 58.
    Perry HM Jr, Davis BR, Price TR et al. (2000) Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 284:465–471CrossRefPubMedGoogle Scholar
  59. 59.
    Pfausler B, Spiss H, Beer R et al. (2003) Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98:1040–1044PubMedGoogle Scholar
  60. 60.
    Phan TG, Koh M, Wijdicks EF (2000) Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 57:1710–1713CrossRefPubMedGoogle Scholar
  61. 61.
    Poungvarin N, Bhoopat W, Viriyavejakul A et al. (1987) Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316:1229–1233PubMedGoogle Scholar
  62. 62.
    Powers WJ, Zazulia AR, Videen TO et al. (2001) Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage. Neurology 57:18–24CrossRefPubMedGoogle Scholar
  63. 63.
    PROGRESS collaborative group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033–1041PubMedGoogle Scholar
  64. 64.
    Qureshi AI, Tuhrim S, Broderick JP et al. (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450–1460CrossRefPubMedGoogle Scholar
  65. 65.
    Radberg JA, Olsson JE, Radberg CT (1991) Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22:571–576PubMedGoogle Scholar
  66. 66.
    Reith J, Jorgensen HS, Pedersen PM et al. (1996) Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 347:422–425PubMedGoogle Scholar
  67. 67.
    Schellinger PD, Jansen O, Fiebach JB et al. (1999) A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage.Stroke 30:765–768PubMedGoogle Scholar
  68. 68.
    Schmutzhard E, Engelhardt K, Beer R et al. (2002) Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med 30:2481–2488CrossRefPubMedGoogle Scholar
  69. 69.
    Schwab S, Spranger M, Schwarz S et al. (1997) Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 48:1608–1613PubMedGoogle Scholar
  70. 70.
    Schwarz S, Schwab S, Steiner HH et al. (1999) Fibrinolysis of intraventricular hematoma with rt-PA. Nervenarzt 70:123–130CrossRefPubMedGoogle Scholar
  71. 71.
    Schwarz S, Hafner K, Aschoff A et al. (2000) Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 54:354–361PubMedGoogle Scholar
  72. 72.
    SHEP cooperative research group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265:3255–3264PubMedGoogle Scholar
  73. 73.
    Sjoblom L, Hardemark HG, Lindgren A et al. (2001) Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32:2567–2574PubMedGoogle Scholar
  74. 74.
    Staessen JA, Fagard R, Thijs L et al. (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic hypertension in Europe (Syst-Eur) trial investigators. Lancet 350:757–764PubMedGoogle Scholar
  75. 75.
    Sudlow CL, Warlow CP (1997) Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International stroke incidence collaboration. Stroke 28:491–499PubMedGoogle Scholar
  76. 76.
    Teernstra OP, Evers SM, Lodder J et al. (2003) Multicenter randomized controlled trial (SICHPA). Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34:968–974CrossRefPubMedGoogle Scholar
  77. 77.
    Tellez H, Bauer RB (1973) Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 4:541–546PubMedGoogle Scholar
  78. 78.
    The Stroke Prevention in Atrial Fibrillation Investigators (1996) Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 156:409–416CrossRefPubMedGoogle Scholar
  79. 79.
    Thrift AG, McNeil JJ, Forbes A et al. (1996) Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 27:2020–2025PubMedGoogle Scholar
  80. 80.
    Thrift AG, McNeil JJ, Forbes A (1998) Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 31:1223–1229PubMedGoogle Scholar
  81. 81.
    Wang JG, Staessen JA, Gong L et al. (2000) Chinese trial on isolated systolic hypertension in the elderly. Systolic hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 160:211–220CrossRefPubMedGoogle Scholar
  82. 82.
    Wang JG, Staessen JA (2001) The benefit of treating isolated systolic hypertension. Curr Hypertens Rep 3:333–339PubMedGoogle Scholar
  83. 83.
    Weimar C, Weber C, Wagner M et al. (2003) Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 15(1–2):29–36Google Scholar
  84. 84.
    Wijdicks EF, Schievink WI, Brown RD et al. (1998) The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 42:769–773PubMedGoogle Scholar
  85. 85.
    Wintzen AR, de Jonge H, Loeliger EA et al. (1984) The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 16:553–558PubMedGoogle Scholar
  86. 86.
    Yasaka M, Minematsu K, Naritomi H, et al. (2003) Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 89:278–283PubMedGoogle Scholar
  87. 87.
    Yu YL, Kumana CR, Lauder IJ et al. (1992) Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 23:967–971PubMedGoogle Scholar
  88. 88.
    Zhu XL, Chan MS, Poon WS (1997) Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 28:1406–1409PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Abteilung Neurologie, Neurologische KlinikUniversitätsklinikum HeidelbergHeidelberg
  2. 2.Neurochirurgische KlinikUniversitätsklinikum HeidelbergHeidelberg
  3. 3.Neurologische KlinikUniversität HeidelbergHeidelberg

Personalised recommendations